The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models

BACKGROUND: Interventions to protect young infants against respiratory syncytial virus (RSV) are in advanced phases of development and are expected to be available in the foreseeable future. Gavi, the Vaccine Alliance, included maternal vaccines and infant monoclonal antibodies for RSV as part of th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Vaccine
Hlavní autoři: Baral, Ranju, Li, Xiao, Willem, Lander, Antillon, Marina, Vilajeliu, Alba, Jit, Mark, Beutels, Philippe, Pecenka, Clint
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier Science 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7342012/
https://ncbi.nlm.nih.gov/pubmed/32586761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.06.036
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky